Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-14

Clinical Trial Update: Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating protective effects of activated charcoal and a probiotic on progression of chronic kidney disease associated with uremic toxins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activated Charcoal (activated charcoal)
  • Probiotic (probiotic)

Snippet

Sponsor: Waleed Khaild Rahman Kareem Al-kabi | Conditions: Uremic Toxin | Phase 2, Phase 3 | Status: UNKNOWN